Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years
Kisicki, James C., MD, Fiske, Kimberly, MPH, Lyne, Andrew, MSc, CStat
Published in Clinical therapeutics (01.09.2007)
Published in Clinical therapeutics (01.09.2007)
Get full text
Journal Article